Zai Lab (ZLAB) Other Operating Expenses (2023)
Zai Lab (ZLAB) posted Other Operating Expenses of $10.0 million for Q2 2023.
Powered by 
Analysis
Zai Lab (ZLAB) Other Operating Expenses (2023) Analysis & Trends
Zai Lab has reported Other Operating Expenses for 1 years, with the latest figure at $10.0 million in Q2 2023.
- Quarterly Other Operating Expenses changed N/A year-over-year to $10.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $10.0 million (changed N/A YoY) and the FY2023 annual result came in at $10.0 million, changed N/A from the prior year.
- Other Operating Expenses held at $10.0 million in Q2 2023 per ZLAB's latest filing.
- Over five years, Other Operating Expenses peaked at $10.0 million in Q2 2023 and troughed at $10.0 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.92 Bn | 2.21 Bn | 58.15 Mn |